New Drug Approved For Colon Cancer

The FDA has approved Eloxatin (Oxaliplatin) for used in combination with Leucovorin for the treatment of the Recurrent Colon Cancer. This combination has shown to shrink tumors and delay progression. We look forward to improved patient survival rates from the drg combination.

Studies are underway, check back for updates.

Webmaster

October 29, 2002